Subscribe free

Cytoreductive Surgery & Peritoneum ·

Laparoscopic HIPEC Triumph: Shorter Recovery in Ovarian Cancer Battle

In the clash of surgical approaches for advanced epithelial ovarian cancer, laparoscopic interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (L-CRS-HIPEC) outshone the open approach. With a significantly shorter hospital stay and faster return to systemic chemotherapy, L-CRS-HIPEC demonstrated comparable oncological outcomes. This study hints at the potential superiority of the laparoscopic approach in selected cases, paving the way for future research to solidify its status as a game-changer in ovarian cancer treatment.

Journal Article by Manuel DM, Gonzalo GD (…) Álvaro AS et 10 al. in Surg Endosc

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Surg Endosc

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Cytoreductive Surgery & Peritoneum.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Cytoreductive Surgery & Peritoneum

The latest stitches

Ann Surg Oncol28 Aug 2026

Prophylactic HIPEC Improves Survival in Advanced Colorectal Cancer

Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.

All papers in Cytoreductive Surgery & Peritoneum →